Small Intestine Bacterial Overgrowth (SIBO) is a condition characterized by an excessive growth of bacteria in the small intestine. It can lead to various gastrointestinal symptoms such as bloating, diarrhea, and abdominal pain. The prevalence of SIBO varies depending on the population studied and the diagnostic criteria used. However, it is estimated that approximately 6-15% of the general population may be affected by SIBO. It is more commonly observed in individuals with certain underlying conditions like irritable bowel syndrome (IBS) or gastrointestinal motility disorders.
Small Intestine Bacterial Overgrowth (SIBO) is a condition characterized by an excessive growth of bacteria in the small intestine. It occurs when the normal balance of bacteria in the gut is disrupted, leading to various digestive symptoms and nutrient malabsorption. The prevalence of SIBO is not precisely known due to variations in diagnostic criteria and testing methods.
However, studies suggest that SIBO is a relatively common condition. It has been estimated that approximately 6-15% of the general population may be affected by SIBO. The prevalence is higher in certain patient populations, such as those with gastrointestinal disorders like irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD), where it can range from 30-85%.
Common risk factors for SIBO include structural abnormalities in the gastrointestinal tract, impaired gut motility, chronic use of proton pump inhibitors or antibiotics, and certain medical conditions that affect digestion. Early recognition and appropriate treatment are crucial to managing SIBO and improving symptoms.